| Year |
Citation |
Score |
| 2011 |
Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Research. 39: 104-18. PMID 20841325 DOI: 10.1093/Nar/Gkq774 |
0.306 |
|
| 2009 |
Fandy TE, Herman JG, Kerns P, Jiemjit A, Sugar EA, Choi SH, Yang AS, Aucott T, Dauses T, Odchimar-Reissig R, Licht J, McConnell MJ, Nasrallah C, Kim MK, Zhang W, et al. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. Blood. 114: 2764-73. PMID 19546476 DOI: 10.1182/Blood-2009-02-203547 |
0.31 |
|
| 2007 |
Choi SH, Byun HM, Kwan JM, Issa JP, Yang AS. Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition. British Journal of Haematology. 138: 616-23. PMID 17686055 DOI: 10.1111/J.1365-2141.2007.06707.X |
0.301 |
|
| 2007 |
Byun H, Eshaghian S, Jiang JY, Choi SH, Soussa J, Ramezani L, Douer D, Yang AS. DNA Methylation Analysis of 807 Genes in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia. Blood. 110: 2122-2122. DOI: 10.1182/Blood.V110.11.2122.2122 |
0.313 |
|
| 2006 |
Choi SH, Byun H, Kwan J, Yang AS. Hydroxyurea with Azacitidine or Decitabine in Combination Is Antagonistic on DNA Methylation Inhibition. Blood. 108: 4303-4303. DOI: 10.1182/Blood.V108.11.4303.4303 |
0.313 |
|
| 2006 |
Choi SH, Byun H, Jiang JY, Garcia-Manero G, Yang AS. Changes in DNA Methylation of Repetitive Elements during the Progression of Chronic Myelogenous Leukemia. Blood. 108: 4302-4302. DOI: 10.1182/Blood.V108.11.4302.4302 |
0.309 |
|
| Show low-probability matches. |